Prof Anders Bjartell discusses the data sources and access of the PIONEER data models
Prof Anders Bjartell discusses the data sources and access of the PIONEER data models
Future directions in glioblastoma: the potential role of TKIs
Optimum duration of adjuvant treatment of stage III colorectal cancer: 3 versus 6 months
State of art in systemic management of nmCRPC
First- and second-line treatments for locally advanced renal cell carcinoma
Surgical management of pancreatic cancer
Advanced HCC: New systemic treatment options
Highlights from IGILUC 2019
PARP inhibitors and their side effects in solid tumour therapy
Treating ovarian cancer patients with PARP inhibitors
Benefits and challenges of using PARP inhibitors to treat metastatic breast cancer
Benefits of cannabis legalisation to patients and oncology professionals